Dostinex is manufactured by Pfizer, Inc.  is the brand name for cabergoline. It belongs to dopamine receptor antagonists group of drugs. The prolactin hormone is released from pituitary gland. Dostinex reduces the amount of prolactin hormone in the blood.  It is often used for management of Parkinson’s disease symptoms. In December 1996, it was approved by the FDA to treat only hyperprolactinemia. Even then many doctors in the United States prescribe Dostinex to patients with Parkinson’s disease. The use of Dostinex in Parkinson’s patients has showed severe and even fatal heart valve damage.

Previous ArticlePfizer facing Dostinex Lawsuits as studies link it with Heart Valve Damage Next ArticleActos Lawsuits
Verdicts and Settlements
Newsletter
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers